This stock could be a wealth destroyer in the next five years.

An explainer on vaccine adjuvant science and safety ...

Activist investor Shah Capital has called on the board of directors at Novavax to put the company up for sale, citing a "litany of missteps" at the company. Chief among its criticisms is Novavax's ...

US FDA's vaccine director Dr. Vinay Prasad wrote a memo to their staff that claimed multiple child deaths were related to COVID-19 vaccines without data to back it up.

The FDA has introduced a stricter set of policies around COVID-19 vaccines, including a clinical trial requirement for new shots intended for widespread use. Any vaccine intended for use in people ...

Novavax, Inc. recently announced at the Jefferies London Healthcare Conference 2025 that it is shifting its focus from direct COVID-19 commercial operations to an expanded research and development ...

Novavax, Inc. (NASDAQ:NVAX) ranks among the most oversold biotech stocks to invest in. Novavax, Inc. (NASDAQ:NVAX) announced ...

The FDA intends to place a black box label—its most serious warning—on COVID-19 vaccines, according to reporting by CNN. It ...

Novavax (NVAX) has been struggling to convince the market that its COVID era gains can translate into a durable vaccine business, and the stock’s recent slide reflects those doubts. See our latest ...

Giant noted that it's not too late get to get a flu vaccine. Giant noted that The Centers for Disease Control and Prevention recommends that everyone six months and older get a flu vaccination ...

The controversial FDA memo, authored by the head of the agency's vaccine division, recommended extensive and potentially costly changes to vaccine regulation. HealthDay News — A confidential internal ...

Meetings are closed to the public, but a summary of discussion is provided below for each meeting. The NACI Chair welcomed participants to the meeting and invited any new declarations of interest as ...